Akari Therapeutics Plc Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Akari Therapeutics Plc quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Akari Therapeutics Plc Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.09 USD/shares, a 69% increase year-over-year.
  • Akari Therapeutics Plc annual Earnings Per Share, Basic for 2023 was -0.61 USD/shares, a 17.6% increase from 2022.
  • Akari Therapeutics Plc annual Earnings Per Share, Basic for 2022 was -0.74 USD/shares.
  • Akari Therapeutics Plc annual Earnings Per Share, Basic for 2021 was 0 USD/shares.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 +$0.20 +69% Apr 1, 2024 Jun 30, 2024 8-K 2024-09-06
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q2 2023 $0 $0 Apr 1, 2023 Jun 30, 2023 8-K 2024-09-06
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 6-K 2022-09-27
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 6-K 2022-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.